These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9396369)
1. [The future of RA treatment]. Matsubara T Ryumachi; 1997 Oct; 37(5):679-80. PubMed ID: 9396369 [No Abstract] [Full Text] [Related]
2. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis. Haraoui B J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467 [TBL] [Abstract][Full Text] [Related]
3. Use of prognostic markets to guide biologic therapies for rheumatoid arthritis. D'Arcy CA; Willkens RF J Rheumatol; 2002 Dec; 29(12):2662; author reply 2662-3. PubMed ID: 12465172 [No Abstract] [Full Text] [Related]
4. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007? Yazici Y; Abramson SB Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549 [TBL] [Abstract][Full Text] [Related]
5. [Rheumatology--a glimpse of a rapidly developing discipline]. Baslund B; Madsen OR; Søndergaard K; Juul L Ugeskr Laeger; 2012 Mar; 174(12):804. PubMed ID: 22433561 [No Abstract] [Full Text] [Related]
8. [Treatment of rheumatoid arthritis. The Danish Society of Rheumatology]. Bestyrelsen Ugeskr Laeger; 2000 Mar; 162(12):1715. PubMed ID: 10745662 [No Abstract] [Full Text] [Related]
9. No B cells--no active RA? Advances in B cell depletion in RA--repeated therapy under conditions of clinical practice. Dörner T; Burmester GR Rheumatology (Oxford); 2007 Apr; 46(4):563-4. PubMed ID: 17337751 [No Abstract] [Full Text] [Related]
10. Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms. Silverman GJ Arthritis Rheum; 2006 Aug; 54(8):2356-67. PubMed ID: 16868991 [No Abstract] [Full Text] [Related]
11. [Use of monoclonal antibodies to tumor necrosis factor (remicade) in rheumatoid arthritis: preliminary results]. Lukina GV; Sigidin IaA; Chichasova NV; Balabanova RM; Belenkiĭ AG; Imametdinova GR; Barskova VG; Bochkova AG; Gukasian DA; Egorova ON; Karateev DE; Kolosova IR; Loginova EIu; Pudovkina EIu; Stanislav ML; Taukumova LA; Fedina TP; Nasonov EL Ter Arkh; 2003; 75(5):9-12. PubMed ID: 12847890 [TBL] [Abstract][Full Text] [Related]
12. Is there a need for new therapies for rheumatoid arthritis? Fleischmann RM J Rheumatol Suppl; 2005 Feb; 73():3-7; discussion 29-30. PubMed ID: 15693109 [TBL] [Abstract][Full Text] [Related]
13. B lymphocyte depletion therapy with rituximab in rheumatoid arthritis. Edwards JC; Leandro MJ; Cambridge G Rheum Dis Clin North Am; 2004 May; 30(2):393-403, viii. PubMed ID: 15172048 [TBL] [Abstract][Full Text] [Related]
15. Treatment and management of early RA: A primary care primer. Costenbader KH; Kountz DS J Fam Pract; 2007 Jul; 56(7 Suppl):S1-7; quiz S8. PubMed ID: 17605944 [TBL] [Abstract][Full Text] [Related]
16. B cells in rheumatology--transforming thinking in rheumatoid arthritis. Panayi GS; Hainsworth JD Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii1-ii2. PubMed ID: 15851521 [No Abstract] [Full Text] [Related]
17. [Rheumatology in Russia in the early 21st century]. Nasonov EL Ter Arkh; 2013; 85(5):4-7. PubMed ID: 23819332 [TBL] [Abstract][Full Text] [Related]
18. Biologic DMARD may be insufficient to inhibit CCL20 pathway in rheumatoid arthritis. Leng RX; Ye DQ J Rheumatol; 2010 Nov; 37(11):2430. PubMed ID: 21041265 [No Abstract] [Full Text] [Related]
19. [Future trends in the treatment and diagnosis of rheumatoid arthritis]. Matsui N Ryumachi; 2000 Oct; 40(5):795-7. PubMed ID: 11215157 [No Abstract] [Full Text] [Related]
20. Cancer drug approved for RA. Health News; 2006 Apr; 12(4):2. PubMed ID: 16572516 [No Abstract] [Full Text] [Related] [Next] [New Search]